[Clinical trial of a new imidazoline derivative with local vasoconstrictive action (H 1032 nasal nebulizer)].
D000336:Aerosols / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D009298:Nasal Polyps / Q000601:surgery*; D009300:Nasal Septum / Q000601:surgery*; D010031:Otitis / Q000601:surgery*; D012220:Rhinitis / Q000601:surgery*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012852:Sinusitis / Q000601:surgery*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D000336:Aerosols; D007093:Imidazoles; D014662:Vasoconstrictor Agents
Sperimentazione clinica di un nuovo derivato imidazolinico ad azione vasocostrittrice locale (H 1032 nebulizzatore nasale)